Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (101-110 of 282) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|May 8, 2012
Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohortCécile Escalas, Marie Dalichampt, Bernard Combe, et al.
The Journal of Rheumatology|July 17, 2014
Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohortGaël Mouterde, Cédric Lukas, Philippe Goupille, et al.
Journal of Autoimmunity|July 4, 2016
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cellsCharlotte Hua, Rachel Audo, Nataliya Yeremenko, et al.
Clinical and Experimental Rheumatology|January 13, 2017
Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-upAnne Tournadre, Bruno Pereira, Jean-Jacques Dubost, et al.
Arthritis Research & Therapy|June 8, 2019
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohortGaël Mouterde, Nathalie Rincheval, Cédric Lukas, et al.
Joint Bone Spine|September 18, 2017
Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective studyCéline Vidal, Cédric Lukas, Bernard Combe, et al.
Annals of the Rheumatic Diseases|June 1, 2013
Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trialXavier Mariette, Stephanie Rouanet, Jean Sibilia, et al.
Arthritis Research & Therapy|September 6, 2008
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective studyNatacha Courvoisier, Maxime Dougados, Alain Cantagrel, et al.
Arthritis Care & Research|September 22, 2021
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-AnalysisAmélie Wetzman, Cédric Lukas, Cécile Gaujoux-Viala, et al.
Clinical and Experimental Rheumatology|August 28, 2018
A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritisMartin Soubrier, Céline Lambert, Bernard Combe, et al.
Pageof 29

Showing results (101-110 of 282) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|May 8, 2012
Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohortCécile Escalas, Marie Dalichampt, Bernard Combe, et al.
The Journal of Rheumatology|July 17, 2014
Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohortGaël Mouterde, Cédric Lukas, Philippe Goupille, et al.
Journal of Autoimmunity|July 4, 2016
A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cellsCharlotte Hua, Rachel Audo, Nataliya Yeremenko, et al.
Clinical and Experimental Rheumatology|January 13, 2017
Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-upAnne Tournadre, Bruno Pereira, Jean-Jacques Dubost, et al.
Arthritis Research & Therapy|June 8, 2019
Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohortGaël Mouterde, Nathalie Rincheval, Cédric Lukas, et al.
Joint Bone Spine|September 18, 2017
Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective studyCéline Vidal, Cédric Lukas, Bernard Combe, et al.
Annals of the Rheumatic Diseases|June 1, 2013
Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trialXavier Mariette, Stephanie Rouanet, Jean Sibilia, et al.
Arthritis Research & Therapy|September 6, 2008
Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective studyNatacha Courvoisier, Maxime Dougados, Alain Cantagrel, et al.
Arthritis Care & Research|September 22, 2021
Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-AnalysisAmélie Wetzman, Cédric Lukas, Cécile Gaujoux-Viala, et al.
Clinical and Experimental Rheumatology|August 28, 2018
A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritisMartin Soubrier, Céline Lambert, Bernard Combe, et al.
Pageof 29